SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-23-159828
Filing Date
2023-06-02
Accepted
2023-06-02 16:05:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFR14A d428853ddefr14a.htm DEFR14A 11709
  Complete submission text file 0001193125-23-159828.txt   12713
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-39617 | Film No.: 23988677
SIC: 2836 Biological Products, (No Diagnostic Substances)